News

Low start dose of Amgen experimental weight-loss drug limits side effects
People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given ...
Fox News19m
Experimental drug helps patients lose nearly a quarter of body weight in early trials
An experimental weight-loss medication was shown to help people lose nearly 25% of their body weight in early-stage 1a/2b trials. The drug, amycretin — developed ... "These results reflect our ...
New Data Shows Just How Powerful the Next Weight-Loss Drugs May Be
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
Healio14m
Once-monthly dosing of novel GLP-1 agonist/GIP antagonist yields substantial weight loss
Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...
GLP-1 Pill From Eli Lilly Leads to Weight Loss and May Be Available Next Year
In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...
New Atlas14h
Ozempic maker announces not one, but three new weight-loss drugs
Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...
Ozempic Alternative May Offer Weight Loss Without Injections or Muscle Loss
A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...
The Next Generation of Weight Loss Drugs Is Coming
Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...
New Atlas2d
New weight-loss drug sails through all-important Phase III trial
A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...